Caplyta Receives FDA Approval as Add-On Treatment for Major Depressive Disorder: A New Hope for Adults Struggling With Depression Health Caplyta Receives FDA Approval as Add-On Treatment for Major Depressive Disorder: A New Hope for Adults Struggling With Depression BuzzScroll News November 16, 2025 Caplyta for depression has recently gained FDA approval as an adjunctive therapy for adults who continue to... Read More Read more about Caplyta Receives FDA Approval as Add-On Treatment for Major Depressive Disorder: A New Hope for Adults Struggling With Depression
